153 related articles for article (PubMed ID: 17182827)
21. Vitamin D and breast cancer: inhibition of estrogen synthesis and signaling.
Krishnan AV; Swami S; Feldman D
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):343-8. PubMed ID: 20156557
[TBL] [Abstract][Full Text] [Related]
22. Phase IIa, randomized placebo-controlled trial of single high dose cholecalciferol (vitamin D
Jarrard D; Konety B; Huang W; Downs T; Kolesar J; Kim KM; Havighurst T; Slaton J; House MG; Parnes HL; Bailey HH
Am J Clin Exp Urol; 2016; 4(2):17-27. PubMed ID: 27766277
[TBL] [Abstract][Full Text] [Related]
23. Prostaglandin metabolising enzymes and PGE2 are inversely correlated with vitamin D receptor and 25(OH)2D3 in breast cancer.
Thill M; Fischer D; Hoellen F; Kelling K; Dittmer C; Landt S; Salehin D; Diedrich K; Friedrich M; Becker S
Anticancer Res; 2010 May; 30(5):1673-9. PubMed ID: 20592360
[TBL] [Abstract][Full Text] [Related]
24. Vitamin D-related therapies in prostate cancer.
Johnson CS; Hershberger PA; Trump DL
Cancer Metastasis Rev; 2002; 21(2):147-58. PubMed ID: 12465754
[TBL] [Abstract][Full Text] [Related]
25. Soy isoflavone genistein in prevention and treatment of prostate cancer.
Perabo FG; Von Löw EC; Ellinger J; von Rücker A; Müller SC; Bastian PJ
Prostate Cancer Prostatic Dis; 2008; 11(1):6-12. PubMed ID: 17923857
[TBL] [Abstract][Full Text] [Related]
26. Prostaglandin (PG) FP and EP1 receptors mediate PGF2alpha and PGE2 regulation of interleukin-1beta expression in Leydig cell progenitors.
Walch L; Clavarino E; Morris PL
Endocrinology; 2003 Apr; 144(4):1284-91. PubMed ID: 12639911
[TBL] [Abstract][Full Text] [Related]
27. Transcriptional inhibition of CYP24 by genistein.
Farhan H; Cross HS
Ann N Y Acad Sci; 2002 Nov; 973():459-62. PubMed ID: 12485911
[TBL] [Abstract][Full Text] [Related]
28. Genistein and AG1024 synergistically increase the radiosensitivity of prostate cancer cells.
Tang Q; Ma J; Sun J; Yang L; Yang F; Zhang W; Li R; Wang L; Wang Y; Wang H
Oncol Rep; 2018 Aug; 40(2):579-588. PubMed ID: 29901146
[TBL] [Abstract][Full Text] [Related]
29. Calcitriol and 20(S)-protopanaxadiol synergistically inhibit growth and induce apoptosis in human prostate cancer cells.
Ben-Eltriki M; Deb S; Adomat H; Tomlinson Guns ES
J Steroid Biochem Mol Biol; 2016 Apr; 158():207-219. PubMed ID: 26709138
[TBL] [Abstract][Full Text] [Related]
30. 3,3'-Diindolylmethane and genistein decrease the adverse effects of estrogen in LNCaP and PC-3 prostate cancer cells.
Smith S; Sepkovic D; Bradlow HL; Auborn KJ
J Nutr; 2008 Dec; 138(12):2379-85. PubMed ID: 19022961
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of nuclear factor kappaB activation in PC3 cells by genistein is mediated via Akt signaling pathway.
Li Y; Sarkar FH
Clin Cancer Res; 2002 Jul; 8(7):2369-77. PubMed ID: 12114442
[TBL] [Abstract][Full Text] [Related]
32. Development of weekly high-dose calcitriol based therapy for prostate cancer.
Beer TM
Urol Oncol; 2003; 21(5):399-405. PubMed ID: 14670552
[TBL] [Abstract][Full Text] [Related]
33. Nanoliposomal formulation encapsulating celecoxib and genistein inhibiting COX-2 pathway and Glut-1 receptors to prevent prostate cancer cell proliferation.
Tian J; Guo F; Chen Y; Li Y; Yu B; Li Y
Cancer Lett; 2019 Apr; 448():1-10. PubMed ID: 30673592
[TBL] [Abstract][Full Text] [Related]
34. Genistein inhibits prostate cancer cell growth by targeting miR-34a and oncogenic HOTAIR.
Chiyomaru T; Yamamura S; Fukuhara S; Yoshino H; Kinoshita T; Majid S; Saini S; Chang I; Tanaka Y; Enokida H; Seki N; Nakagawa M; Dahiya R
PLoS One; 2013; 8(8):e70372. PubMed ID: 23936419
[TBL] [Abstract][Full Text] [Related]
35. Intracrine prostaglandin E
Madrigal-Martínez A; Fernández-Martínez AB; Lucio Cazaña FJ
J Cell Physiol; 2018 Apr; 233(4):3590-3602. PubMed ID: 29154474
[TBL] [Abstract][Full Text] [Related]
36. Reciprocal cross talk between gonadotropin-releasing hormone (GnRH) and prostaglandin receptors regulates GnRH receptor expression and differential gonadotropin secretion.
Naor Z; Jabbour HN; Naidich M; Pawson AJ; Morgan K; Battersby S; Millar MR; Brown P; Millar RP
Mol Endocrinol; 2007 Feb; 21(2):524-37. PubMed ID: 17138645
[TBL] [Abstract][Full Text] [Related]
37. Genistein-Calcitriol Mitigates Hyperosmotic Stress-Induced TonEBP, CFTR Dysfunction, VDR Degradation and Inflammation in Dry Eye Disease.
Panigrahi T; D'Souza S; Shetty R; Padmanabhan Nair A; Ghosh A; Jacob Remington Nelson E; Ghosh A; Sethu S
Clin Transl Sci; 2021 Jan; 14(1):288-298. PubMed ID: 32896986
[TBL] [Abstract][Full Text] [Related]
38. Enhancement of experimental colon cancer by genistein.
Rao CV; Wang CX; Simi B; Lubet R; Kelloff G; Steele V; Reddy BS
Cancer Res; 1997 Sep; 57(17):3717-22. PubMed ID: 9288778
[TBL] [Abstract][Full Text] [Related]
39. Requirement of cyclooxygenase-2 expression and prostaglandins for human prostate cancer cell invasion.
Nithipatikom K; Isbell MA; Lindholm PF; Kajdacsy-Balla A; Kaul S; Campell WB
Clin Exp Metastasis; 2002; 19(7):593-601. PubMed ID: 12498388
[TBL] [Abstract][Full Text] [Related]
40. Genistein treatment duration effects biomarkers of cell motility in human prostate.
Zhang H; Gordon R; Li W; Yang X; Pattanayak A; Fowler G; Zhang L; Catalona WJ; Ding Y; Xu L; Huang X; Jovanovic B; Kelly DL; Jiang H; Bergan R
PLoS One; 2019; 14(3):e0214078. PubMed ID: 30917169
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
